Shikha Shrivastava

Shikha Shrivastava

Auto-generated profile, based on publicly available information

Shikha Shrivastava

Laboratory of Adjuvant and Antigen Research, U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2021 in npj Vaccines
Verified
Journal Article
Open access
PDF file
JCJoshua M. Carmen
Joshua M. Carmen
SSShikha Shrivastava
Shikha Shrivastava
ZLZhongyan Lu
Zhongyan Lu
AAAlexander Anderson
Alexander Anderson
EMElaine B. Morrison
Elaine B. Morrison
MRMangalo Rao
Mangalo Rao
The emergence of variants of concern, some with reduced susceptibility to COVID-19 vaccines underscores consideration for the understanding of vaccine design that optimizes induction of effective cellular and humoral immune responses. We assessed a SARS-CoV-2 spike-ferritin nanoparticle (SpFN) immunogen paired with two distinct adjuvants, Alhydrogel® or Army Liposome Formulation containing QS-21 (ALFQ) for unique vaccine evoked immune signatures. Recruitment of highly activated multifaceted antigen-presenting cells to the lymph nodes of SpFN+ALFQ vaccinated mice was associated with an increased frequency of polyfunctional spike-specific memory CD4+ T cells and Kb spike-(539–546)-specific long-lived memory CD8+ T cells with effective cytolytic function and distribution to the lungs. The presence of this epitope in SARS-CoV, suggests that generation of cross-reactive T cells may be induced against other coronavirus strains. Our study reveals that a nanoparticle vaccine, combined with a potent adjuvant that effectively engages innate immune cells, enhances SARS-CoV-2-specific durable adaptive immune T cell responses.

4 May 2017 in Journal of Viral Hepatitis
Verified
Journal Article
Closed access
PDF file
SSS. Shrivastava
S. Shrivastava
EWEleanor Wilson
Eleanor Wilson
BPB. Poonia
B. Poonia
LTL. Tang
L. Tang
AOA. Osinusi
A. Osinusi
SKShyam Kottilil
Shyam Kottilil

18 March 2023 in npj Vaccines
Verified
Journal Article
Open access
PDF file
SSShikha Shrivastava
Shikha Shrivastava
JCJoshua M. Carmen
Joshua M. Carmen
ZLZhongyan Lu
Zhongyan Lu
Shraddha BasuShraddha Basu
Shraddha Basu
RSRajeshwer S. Sankhala
Rajeshwer S. Sankhala
MRMangalo Rao
Mangalo Rao
This study demonstrates the impact of adjuvant on the development of T follicular helper (Tfh) and B cells, and their influence on antibody responses in mice vaccinated with SARS-CoV-2-spike-ferritin-nanoparticle (SpFN) adjuvanted with either Army Liposome Formulation containing QS-21 (SpFN + ALFQ) or Alhydrogel®(SpFN + AH). SpFN + ALFQ increased the size and frequency of germinal center (GC) B cells in the vaccine-draining lymph nodes and increased the frequency of antigen-specific naive B cells. A single vaccination with SpFN + ALFQ resulted in a higher frequency of IL-21-producing-spike-specific Tfh and GC B cells in the draining lymph nodes and spleen, S-2P protein-specific IgM and IgG antibodies, and elicitation of robust cross-neutralizing antibodies against SARS-CoV-2 variants as early as day 7, which was enhanced by a second vaccination. This was associated with the generation of high titer, high avidity binding antibodies. The third vaccination with SpFN + ALFQ elicited high levels of neutralizing antibodies against the Omicron variant. No cross-neutralizing antibodies against Omicron were induced with SpFN + AH. These findings highlight the importance of ALFQ in orchestrating early induction of antigen-specific Tfh and GC B cell responses and long-lived plasma cells in the bone marrow. The early engagement of S-2P specific naive B cells and high titer IgM antibodies shape the development of long-term neutralization breadth.

1 January 2016
Verified
Book Chapter
Closed access
DSDeependra Singh
Deependra Singh
MPMadhulika Pradhan
Madhulika Pradhan
SSShikha Shrivastava
Shikha Shrivastava
SMS. Narasimha Murthy
S. Narasimha Murthy
MSManju Singh
Manju Singh